Fact CheckerSign in

NCT07750444Active, not recruiting

Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

The Growth study investigates nutritional status, BMI, and linear growth trajectories from birth to adulthood in childhood cancer patients and survivors. Specifically, it aims to identify the predictors driving these distinct growth and weight trajectories and evaluate the consistency of these findings across multiple European countries. The study will make use of routine collected clinical data from oncology centres. Additional information about diagnoses, treatments, sociodemographic, and lifestyle data are obtained by linkages with disease and population registries, and with previously conducted questionnaire studies among survivors. The study will provide insights into the nutritional status of childhood cancer patients and survivors and improve understanding of growth patterns in this population.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
12150 (estimated)
First submitted
13 Jul 2026
Start date
1 Oct 2025
Primary completion date
Nov 2027
Lead sponsor
Fabiën Belle
NCT number
NCT07750444

What you commit to

  • Study type: Observational
  • Planned participants: 12150
  • From 1 Oct 2025 to the primary completion date, Nov 2027
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Diagnosed with cancer at age \<20 years
  • Diagnosed between 2004 and 2026
  • Treated in one of the participating cancer centres:
    • Switzerland: patients who visited one of the cancer centres in Switzerland: Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, St. Gallen, Zurich.
    • Portugal: patients diagnosed between 2012-2026 at the Portuguese paediatric oncology centres Instituto Português de Oncologia do Porto Francisco Gentil - IPO-PORTO or at the Instituto Português de Oncologia Francisco Gentil - IPOLFG.
    • Slovenia: patients diagnosed between 2011-2026 at the paediatric oncology clinic University Medical Center Ljubljana.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kantonsspital Aarau AG
Coordinator of this site? Confirm its status
AarauSwitzerlandUnknown status
Universitäts-Kinderspital beider Basel (UKBB)
Coordinator of this site? Confirm its status
BaselSwitzerlandUnknown status
Ospedale Regionale Di Bellinzona
Coordinator of this site? Confirm its status
BellinzonaSwitzerlandUnknown status
Kinderklinik, Inselspital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status
Institute of Social and Preventive Medicine (ISPM), Universität Bern
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status
Hôpitaux Universitaires de Genève (HUG)
Coordinator of this site? Confirm its status
GenevaSwitzerlandUnknown status
Centre Hospitalier Universitaire Vaudois (CHUV)
Coordinator of this site? Confirm its status
LausanneSwitzerlandUnknown status
Kinderspital Zentralschweiz, Luzern
Coordinator of this site? Confirm its status
LucerneSwitzerlandUnknown status
HOCH Health Ostschweiz - Kantonsspital St. Gallen
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandUnknown status
Ostschweizer Kinderspital
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandUnknown status
Kinderspital Zürich
Coordinator of this site? Confirm its status
ZurichSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.